Cervarix™, the GSK HPV-16/HPV-18 AS04-adjuvanted Cervical Cancer Vaccine, Demonstrates Stability Upon Long-Term Storage and Under Simulated Cold Chain Break Conditions

Human Vaccines
doi 10.4161/hv.8485
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Erratum To: Prevalence and Incidence of Human Papillomavirus (HPV) Infection Before and After Pregnancy: Pooled Analysis of the Control Arms of Efficacy Trials of HPV-16/18 AS04-Adjuvanted Vaccine

Open Forum Infectious Diseases
OncologyNeurology
2020English

Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine

Drugs
Pharmacology
2011English

Safety of the AS04-adjuvanted Human Papillomavirus (HPV)-16/18 Vaccine in Adolescents Aged 12–15 Years: End-Of-Study Results From a Community-Randomized Study Up to 6.5 Years

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2019English

PDZRN3/LNX3 Is a Novel Target of Human Papillomavirus Type 16 (HPV-16) and HPV-18 E6

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2014English

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands

PLoS ONE
Multidisciplinary
2016English

PS1-25: The Impact of HPV Vaccination Upon Optimal Cervical Cancer Screening Strategies

Clinical Medicine and Research
MedicineHome CareCommunity
2011English

Efficacy, Immunogenicity and Safety of the AS04‐HPV‐16/18 Vaccine in Chinese Women Aged 18‐25 Years: End‐of‐study Results From a Phase II/III, Randomised, Controlled Trial

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Cervical Cancer in Women With HPV

Amadeus International Multidisciplinary Journal
2018English

Cervical Cancer and Human Papilloma Virus (HPV) – Viral Cervical Cancer

MOJ Cell Science & Report
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy